Peter Bläuenstein
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 5%
- Peptidase Inhibition and Analysis
Papers in
-
- Radiopharmaceutical Chemistry and Applications 29
- Monoclonal and Polyclonal Antibodies Research 6
- Medical Imaging Techniques and Applications 6
- Oncology 13
- Peptidase Inhibition and Analysis 11
- Co-authors
- Pius August Schubiger (27 shared papers)Dirk Tourwé (19 shared papers)Elisa García‐Garayoa (12 shared papers)Véronique Maes (10 shared papers)Elisa Garcı́a Garayoa (10 shared papers)Alain Blanc (10 shared papers)Roger Schibli (12 shared papers)Annette G. Beck‐Sickinger (4 shared papers)
- Journals
- Nuclear Medicine and Biology (9 papers)Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry (4 papers)European Journal of Nuclear Medicine and Molecular Imaging (3 papers)Bioconjugate Chemistry (3 papers)Helvetica Chimica Acta (2 papers)
- Partner nations
- SwitzerlandBelgiumGermany
In The Last Decade
Peter Bläuenstein
55 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 100
- Radiology, Nuclear Medicine and Imaging 932
- Oncology 581
- Cellular and Molecular Neuroscience 286
- Filtration and Separation 18
- Epidemiology 268
Countries citing papers authored by Peter Bläuenstein
This map shows the geographic impact of Peter Bläuenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bläuenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bläuenstein more than expected).
Fields of papers citing papers by Peter Bläuenstein
This network shows the impact of papers produced by Peter Bläuenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bläuenstein. The network helps show where Peter Bläuenstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Bläuenstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Radiolabeled neurotensin analog, 99mTc-NT-XI, evaluated in ductal pancreatic adenocarcinoma patients. | 2003 | 87 |
| 2 | 2001 | 85 | |
| 3 | 2008 | 83 | |
| 4 | 2002 | 82 | |
| 5 | 2002 | 79 | |
| 6 | 2006 | 76 | |
| 7 | 2005 | 75 | |
| 8 | 1995 | 74 | |
| 9 | 2008 | 63 | |
| 10 | Preclinical evaluation of a new, stabilized neurotensin(8--13) pseudopeptide radiolabeled with (99m)tc. | 2002 | 60 |
| 11 | 2002 | 58 | |
| 12 | 2008 | 57 | |
| 13 | Measurement of the extracellular space in brain tumors using 76Br-bromide and PET. | 2003 | 55 |
| 14 | 1980 | 49 | |
| 15 | 2006 | 47 | |
| 16 | 2006 | 45 | |
| 17 | New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors. | 2007 | 44 |
| 18 | 2013 | 34 | |
| 19 | 1999 | 32 | |
| 20 | 1975 | 32 |
About Peter Bläuenstein
Peter Bläuenstein is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Cellular and Molecular Neuroscience, Organic Chemistry and Pharmaceutical Science, having authored 55 papers that have together received 1.6k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (29 papers), Peptidase Inhibition and Analysis (11 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Medical Imaging Techniques and Applications (6 papers), Neuroendocrine Tumor Research Advances (5 papers), Medical Imaging and Pathology Studies (4 papers), Chemical Reactions and Isotopes (3 papers) and Radioactive element chemistry and processing (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (932 citations), Oncology (581 citations), Cellular and Molecular Neuroscience (286 citations), Filtration and Separation (18 citations) and Epidemiology (268 citations). Peter Bläuenstein has collaborated with scholars based in Switzerland, Belgium and Germany. Frequent co-authors include Pius August Schubiger, Dirk Tourwé, Elisa García‐Garayoa, Véronique Maes, Elisa Garcı́a Garayoa, Alain Blanc, Roger Schibli, Annette G. Beck‐Sickinger, Giorgio Anderegg and Ilse Novak‐Hofer. Their work appears in journals such as Nuclear Medicine and Biology, Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry, European Journal of Nuclear Medicine and Molecular Imaging, Bioconjugate Chemistry and Helvetica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.